Kari Ring (@KariLRing) profile picture

Kari Ring

@KariLRing

Gynecologic Oncologist

 Charlottesville, VA
Joined March 2014
  • Tweets17
  • Following59
  • Followers108
Exciting to share treatment options that are better than chemotherapy for women with #endometrialcancer #clinicaltrial #gyncsm #endcancer #oncsurgery @karenluMD @rcoledude @ShannonWestin @DavidIglesiasMD @MDAndersonNews
Clinical Cancer Research (@CCR_AACR) profile pictureClinical Cancer Research@CCR_AACR25 Oct 2019
Phase 2 #ClinicalStudy shows #CombinationTherapy using #everolimus, #letrozole and #metformin results in #ClinicalBenefit for 50% of patients with recurrent endometrioid #EndometrialCancer Soliman et al report @mdandersonnews @PamSolimanMD bit.ly/2MNjZBz
Image from Clinical Cancer Research (@CCR_AACR)
3
21
3
61
Kari Ring retweeted
BJ Rimel (@BJRimelMD) profile picture
BJ Rimel@BJRimelMD3 Jun 2019
Seems like we are done with MIS for cervical cancer. Even distance from margin was the same and the “less worrisome” uterine manipulators were showed higher rates of recurrence. The only thing left is the CO2....
Deanna Teoh, M.D., M.S., FACOG (@DeannaTeoh) profile pictureDeanna Teoh, M.D., M.S., FACOG@DeannaTeoh3 Jun 2019
Final nail in the coffin for MIS rad hyst for #cervicalcancer? Another well-executed multicenter retrospective study showing decreased PFS and OS even for tumor <2cm, robotics, and regardless of uterine manipulator.… instagram.com/p/ByQnvyEgnPU/…
6
2
15
Kari Ring retweeted
OncLive.com (@OncLive) profile picture
OncLive.com
@OncLive17 Jan 2019
Dr. Katherine Kurnit, of @MDAndersonNews, walked us through her study comparing whether a gynecologic or gastrointestinal regimen is better for patients with mucinous ovarian cancer who are dispositioned to receive chemo. Stay tuned for the interview! #SGOWinter #SGO2019 @SGO_org
Image from OncLive.com (@OncLive)
1
5
1
13
Another great talk at the @GYNCancer #Survivor course - @temkins breaking down #CA125 in #ovariancancer #gyncsm
BJ Rimel (@BJRimelMD) profile pictureBJ Rimel@BJRimelMD17 Nov 2018
⁦@temkins⁩ “Go Science” #ca125 the role of surveillance in ovarian cancer. ⁦@GYNCancer⁩ ⁦@SGO_org⁩
Image from BJ Rimel (@BJRimelMD)
3
8
We're talking about digital health with @BJRimelMD and the foundation for women's cancer. #gyncsm #ovariancancer #survivors course #RVA
Image from Sarah Temkin (@temkins)
1
1
7
Replying to @ShannonWestin
@ShannonWestin talks clinical trials in #RVA for #ovariancancer #gyncsm @SGO_org
Image from Sarah Temkin (@temkins)
4
1
9
Amazing data for the olaparib maintenance after the first line chemotherapy in advanced #ovariancancer with somatic it germline BRCA mutation presented at #ESMO18 #PrecisionMedicine
Image from Filip Janku (@FilipJankuMD)
5
8
SGO recommends genetic testing for all women dx w #ovca. even if no family history - a new position paper cancernetwork.com/practice-p… #gyncsm
1
7
1
2
Data from older clinical trials now available to researchers for new discoveries! #sgo2014 medcitynews.com/2014/04/sano…

To spark cancer discoveries, several Big Pharma companies are sharing idle clinical trial data -...

Sanofi, Pfizer, J&J and AstraZeneca are among Big Pharma companies sharing cancer clinical trial data on the new Project Data Sphere platform.

medcitynews.com
3
1
Anastrozole Reduces Breast Cancer Incidence in High-Risk Postmenopausal Women ow.ly/vhGfQ #bcsm
3
2
Kari Ring retweeted
SGO (@SGO_org) profile picture
SGO@SGO_org1 Apr 2014
Women with BRCA1 mutation might use medications to reduce their risk of developing breast and ovarian cancer. sciencedaily.com/releases/20…
7
2
ascopost.com/ViewNews.aspx?n… #SGO2014
4
4
4
GOG 249 presented at SGO. Chemotherapy not superior to Pelvic XRT in high-intermediate risk uterine carcinoma. #SGO2014
4
2
GOG 249 Endometrial ca trial Dr McMeekin conclusions slide – at Tampa, FL
Image from Nadeem R. Abu-Rustum (@aburustummd)
1
1
Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. staging-www.nature.com/ng/jo…
1
4
2
Load more